Novartis hands over experimental TB drugs in antibiotic pullback

August 20, 2014 12:25 PM

8 0

Novartis hands over experimental TB drugs in antibiotic pullback

ZURICH (Reuters) - Novartis has signed a licensing deal to hand over its experimental tuberculosis (TB) drugs to the Global Alliance for TB Drug Development, joining a growing Big Pharma retreat from antibiotics.

The TB Alliance deal reflects renewed scrutiny of the Novartis portfolio under new chairman Joerg Reinhardt, who is focusing the Swiss company's research on core areas such as cancer, respiratory drugs, heart failure and dermatology.

Also read: REFILE-UPDATE 1-Baker Hughes to form fracturing JV with Goldman Sachs, CSL Capital

Read more

To category page

Loading...